Elevance Health (ELV)

Deferred Revenue

$1.64B

Quarterly · Period ending: · USD

ELV logo

ELV Deferred Revenue

Latest reported$1.64B
ELV Quarterly Deferred Revenue ($0.00 → $1.64B)
High-resolution chart · PNG

ELV deferred revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Elevance Health Deferred Revenue — Quarterly (USD)
Period endingDeferred Revenue (USD)
1,640,000,000
1,759,000,000
1,493,000,000
0
1,561,000,000
1,640,000,000
1,508,000,000
1,793,000,000
1,481,000,000
1,474,000,000
1,402,000,000
4,332,000,000
4,458,000,000
4,394,000,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
971,900,000
1,613,400,000
832,800,000
1,021,300,000
1,145,500,000
945,100,000
950,500,000
1,079,800,000
1,078,100,000
1,003,500,000
953,500,000
1,073,000,000
822,700,000
939,700,000
823,600,000
865,700,000
896,800,000
823,700,000
1,707,800,000
1,624,100,000
926,500,000
1,638,600,000
1,038,100,000
1,048,000,000
891,400,000
989,400,000
1,035,200,000
1,117,700,000
1,050,000,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.